Nine patents awarded to Vanderbilt technologies in April

Nine Vanderbilt technologies were awarded U.S. patent protection in April. The technologies range from new therapeutic compounds to a heat transfer fluid.

8,710,074

Dihydronaphthyridinyl(organo)methanone analogs as positive allosteric mGluR5 modulators

8,709,280

Polar nematic compounds

8,703,946

Substituted pyrazolo[1,5-A]pyrazine compounds as allosteric modulators of mGluR5 receptors

8,703,665

Materials comprising deaggregated diamond nanoparticles

8,697,888

Substituted (1-(methylsulfonyl)azetidin-3-yl)(heterocycloalkyl)methanone analogs as antagonists of muscarinic acetylcholine M.sub.1 receptors

8,697,691

Alkyl 3-((2-amidoethyl)amino)-8-azabicyclo[3.2.1]octane-8-carboxylate analogs as selective M1 agonists and methods of making and using same

8,697,447

Cleavable surfactants and methods of use thereof

8,696,933

Polar nematic compounds

8,691,556

Methods and compositions for vein harvest and autografting

Featured Video

Vanderbilt Patent Activity

View Vanderbilt University Patents

CTTC on Twitter